Methylprednisolone (MP) can be used to treat a variety of neurological disorders involving white matter injury, including multiple sclerosis, acute disseminated encephalomyelitis, and spinal cord injury (SCI). presence or absence of RU486. Eight days after SCI, MP significantly increased oligodendrocytes (CC-1 immunoreactive cells) following SCI, but neuronal IWP-2 kinase activity assay (NeuN immunoreactive cells) number… Continue reading Methylprednisolone (MP) can be used to treat a variety of neurological